Key Details
The WHO’s Guideline on the Integrated Management of Obesity in Adolescents sets out how primary care and specialist services can provide continuing, coordinated treatment, rather than relying on a single intervention.
Place in Care | WHO Recommendation |
|---|---|
Core treatment | Combine personalised dietary support, physical activity and behaviour-change interventions. Consider sleep, mental health, cultural context and the adolescent’s preferences; involve parents or caregivers. |
Digital tools | Apps, activity trackers and similar tools may support care, but WHO’s recommendation is conditional. |
Medicines | Consider only for adolescents with obesity-related complications after at least six months of structured, supervised lifestyle treatment has not achieved sufficient improvement. Prescribing requires specialist multidisciplinary care and follow-up. |
Bariatric surgery | Consider only for adolescents meeting WHO’s severe-obesity criteria after supervised treatment has not achieved sufficient improvement. Assessment, surgery and long-term follow-up require specialist multidisciplinary care. |
WHO could not make a recommendation on weight-loss or weight-management devices because evidence was insufficient.
Treatment Starts With the Adolescent’s Overall Health
The guideline treats obesity as a complex chronic condition, with consequences that can extend beyond body weight to physical functioning, mental well-being and quality of life. Its recommended starting point is a structured combination of nutrition, activity and behaviour-change support, supervised by appropriately trained health workers.
Care should take account of food access, disability, sleep, mental health and the adolescent’s own goals. Family participation matters, but it does not replace the adolescent’s involvement in decisions. WHO also calls for empathetic, non-stigmatising communication and assessment of issues such as eating-disorder risk.
Medicines and Surgery Have Stricter Conditions
WHO’s guidance does not position medication as a first response or a stand-alone treatment. It suggests medicines only when obesity-related complications are present and at least six months of supervised combined treatment has not achieved sufficient improvement. Evidence on longer-term benefits and adverse effects remains limited.
Surgery has an even narrower role. WHO specifies severe-obesity thresholds, careful assessment of physical and psychological development, informed decision-making and long-term follow-up. These recommendations describe clinical options for eligible adolescents; they do not mean either intervention is suitable for every adolescent with obesity.
Strong Recommendations Do Not Mean Strong Evidence
WHO strongly recommends dietary, physical-activity, behaviour-change and combined interventions, although it rates much of the underlying evidence as very low certainty. In reaching those recommendations, it also considered potential harms, adolescents’ and caregivers’ preferences, feasibility, cost and equity.
Much of the treatment research comes from high-income countries. The guideline therefore calls for better evidence on long-term outcomes, safety, costs and delivery in low- and middle-income settings.
Policy Relevance
The guideline is a reference for adapting adolescent obesity care. Its most immediate implication is for the care pathway: primary-care workers need a way to address nutrition, activity and mental health together, with referral to specialist teams when complications or severe obesity warrant it.
Access shapes whether that pathway is workable. Affordable healthy food, safe opportunities for activity and follow-up care differ across families and locations. India-specific evidence on treatment outcomes and costs would help determine how to deliver WHO’s recommendations without widening those gaps.
Follow the Full Guideline Here: WHO, Guideline on the Integrated Management of Obesity in Adolescents